AICAR has garnered significant attention in recent years due to its potential therapeutic and performance-enhancing properties. This compound, also known as ZMP or AICA ribonucleotide, has been the subject of numerous studies exploring its effects on metabolism, exercise performance, and various health conditions. In this comprehensive guide, we'll delve into the nature of AICAR, its uses, mechanisms of action, and legal status to answer the question: Is AICAR a drug?
Product Code: BM-2-4-137
CAS number:2627-69-2
Molecular formula: C9H14N4O5
Molecular weight: 258.23
EINECS number: 220-097-5
MDL No.: MFCD00869751
Hs code: 29349990
Analysis items: HPLC>99.0%, LC-MS
Main market: USA, Australia, Brazil, Japan, Germany, Indonesia, UK, New Zealand , Canada etc.
Manufacturer: BLOOM TECH Changzhou Factory
Technology service: R&D Dept.-4
We provide Aicar Powder CAS 2627-69-2, please refer to the following website for detailed specifications and product information.
Product: https://www.bloomtechz.com/synthetic-chemical/peptide/aicar-powder-cas-2627-69-2.html
AICAR Uses: Medical and Performance Benefits
AICAR has been investigated for a wide range of potential applications, both in medical settings and for performance enhancement. Let's explore some of the most notable uses:
Medical Applications
AICAR has shown promise in several medical areas:
- Metabolic disorders: Research suggests it may help improve insulin sensitivity and glucose uptake, making it a potential candidate for treating type 2 diabetes and obesity.
- Cardiovascular health: Studies indicate that it might protect against ischemia-reperfusion injury and improve cardiac function.
- Cancer treatment: Some research has explored it's potential in inhibiting tumor growth and enhancing the effectiveness of certain cancer therapies.
- Neurological conditions: Preliminary studies have investigated it's neuroprotective properties, suggesting potential benefits for conditions like Alzheimer's disease and stroke.
Performance Enhancement
Beyond its medical applications, AICAR has gained attention in the world of sports and athletics:
- Endurance improvement: AICAR has been dubbed an "exercise pill" due to its potential to enhance endurance and aerobic capacity without physical training.
- Muscle metabolism: Research indicates that it may influence muscle fiber composition and improve fat oxidation during exercise.
- Recovery: Some studies suggest it might aid in post-exercise recovery by reducing inflammation and oxidative stress.
While these potential benefits are intriguing, it's crucial to note that most research on AICAR has been conducted in laboratory settings or animal models. Human trials are limited, and the long-term effects and safety profile of AICAR in humans are not yet fully understood.
|
|
|
How AICAR Works: Mechanism and Effects
To understand whether AICAR can be classified as a drug, it's essential to examine its mechanism of action and effects on the body.
AMPK Activation
The primary mechanism of action for AICAR is the activation of AMP-activated protein kinase (AMPK). AMPK is often referred to as a "metabolic master switch" due to its crucial role in regulating energy homeostasis. When activated, AMPK triggers a cascade of cellular responses that mimic the effects of exercise:
- Increased glucose uptake by muscles
- Enhanced fatty acid oxidation
- Mitochondrial biogenesis
- Inhibition of protein synthesis
By activating AMPK, AICAR essentially "tricks" cells into believing they are in an energy-depleted state, prompting them to increase energy production and efficiency.
Metabolic Effects
The activation of AMPK by AICAR leads to several metabolic effects:
- Improved insulin sensitivity: AICAR may enhance glucose uptake in skeletal muscle and reduce insulin resistance.
- Fat metabolism: It can increase the breakdown of fatty acids and reduce lipid accumulation in tissues.
- Muscle adaptation: AICAR may promote the formation of slow-twitch muscle fibers, which are associated with improved endurance.
- Mitochondrial function: By stimulating mitochondrial biogenesis, the product can potentially improve cellular energy production.
Cellular and Molecular Effects
At the cellular and molecular level, AICAR exerts various effects:
- Gene expression: AICAR can influence the expression of genes involved in metabolism, inflammation, and cell survival.
- Protein synthesis: It may inhibit the mTOR pathway, which is involved in protein synthesis and cell growth.
- Autophagy: AICAR can promote autophagy, a cellular "cleaning" process that removes damaged components and may contribute to longevity.
- Oxidative stress: Some studies suggest AICAR may have antioxidant properties, helping to protect cells from oxidative damage.
These diverse effects at the cellular and molecular level contribute to AICAR's potential therapeutic and performance-enhancing properties. However, they also highlight the complexity of its actions and the need for careful consideration of its use.
|
|
|
AICAR Legality: Regulations and Restrictions
The legal status of AICAR is a complex issue that varies depending on the context and jurisdiction. Let's explore the current regulatory landscape:
Research and Medical Use
In research settings, AICAR is generally considered a chemical compound rather than a drug. It's widely used in laboratory studies to investigate cellular metabolism and related processes. However, its status changes when considering potential medical applications:
- Clinical trials: AICAR has been used in some clinical trials, where it's regulated as an investigational drug subject to strict protocols and oversight.
- Prescription status: As of now, AICAR is not approved as a prescription medication by major regulatory bodies like the FDA or EMA.
Sports and Athletics
In the realm of sports, AICAR is classified as a prohibited substance:
- World Anti-Doping Agency (WADA): AICAR is included on WADA's Prohibited List under the category of "Hormone and Metabolic Modulators."
- Professional sports leagues: Many professional sports organizations follow WADA guidelines or have similar prohibitions on AICAR use.
- Testing: Detection methods for AICAR have been developed and are used in anti-doping screenings.
Regulatory Gray Areas
Despite clear regulations in sports, AICAR exists in a regulatory gray area in other contexts:
- Dietary supplements: Some companies have attempted to market the product as a dietary supplement, although this is generally not considered legal or appropriate.
- Research chemicals: AICAR is sometimes sold as a "research chemical," but its use outside of legitimate research settings may violate regulations.
- International variations: Regulations regarding AICAR can vary significantly between countries, adding to the complexity of its legal status.
Future Regulatory Outlook
As research on AICAR continues and its potential applications become clearer, its regulatory status may evolve:
- Medical approval: If clinical trials demonstrate safety and efficacy, AICAR or related compounds could potentially gain approval as prescription medications for specific conditions.
- Tighter controls: Conversely, concerns about misuse might lead to stricter regulations on AICAR's distribution and use.
- Ethical considerations: The potential of AICAR as an "exercise mimetic" raises ethical questions that may influence future regulatory decisions.
In conclusion, while AICAR is not currently classified as a drug in the traditional sense of a approved medication, its potential effects and use in research and sports contexts place it in a complex regulatory landscape. Its classification can vary depending on the specific context and jurisdiction, ranging from a research tool to a prohibited substance in competitive sports.
The question "Is AICAR a drug?" doesn't have a simple yes or no answer. AICAR's status lies at the intersection of biochemistry, pharmacology, and regulatory science. As research progresses and our understanding of AICAR's effects and potential applications deepens, its classification and regulation may continue to evolve.
For those interested in the latest developments in AICAR research or related compounds, it's crucial to stay informed about current regulations and consult with qualified professionals. If you have questions about AICAR or similar substances, don't hesitate to reach out to experts in the field.
For more information on AICAR and related research chemicals, please contact us at Sales@bloomtechz.com. Our team of experts is always ready to provide the most up-to-date information and guidance on these fascinating compounds.
References
Narkar, V. A., et al. (2008). AMPK and PPARδ agonists are exercise mimetics. Cell, 134(3), 405-415.
Merrill, G. F., et al. (1997). AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. American Journal of Physiology-Endocrinology and Metabolism, 273(6), E1107-E1112.
Thevis, M., et al. (2009). Determination of the prevalence of anabolic steroids, stimulants, and selected drugs subject to doping controls among elite sport students using analytical chemistry. Journal of Sports Sciences, 27(10), 1025-1034.
Coughlan, K. A., et al. (2014). AMPK activation: a therapeutic target for type 2 diabetes? Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 7, 241-253.